PRKAA2 and cancer: Although the underlying mechanism remains to be uncovered, these inhibitory phosphorylations on the ST-loop may represent a negative regulatory circuit to turn off AMPK signaling when the proliferative metabolic signaling is forced to work, for example, in cancers harboring a constitutively active PKB/Akt mutation.